Matches in Wikidata for { <http://www.wikidata.org/entity/Q100493791> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q100493791 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100493791 description "scientific article published on 08 October 2020" @default.
- Q100493791 description "wetenschappelijk artikel" @default.
- Q100493791 description "наукова стаття, опублікована 8 жовтня 2020" @default.
- Q100493791 name "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 name "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 name "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 type Item @default.
- Q100493791 label "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 label "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 label "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 prefLabel "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 prefLabel "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 prefLabel "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 P1433 Q100493791-FCF22AE6-1312-4B02-92B8-EB95F5B3BB31 @default.
- Q100493791 P1476 Q100493791-DB9B1507-8291-4026-AB60-5B9A5A85EEC8 @default.
- Q100493791 P2093 Q100493791-40E64125-0AB4-495A-BCD7-CC55B06A69F3 @default.
- Q100493791 P2093 Q100493791-6DDE6C7A-27E8-4CDF-9D47-56519B10512F @default.
- Q100493791 P304 Q100493791-C5C6A03C-4D39-4C24-80BE-819B8E33BCF9 @default.
- Q100493791 P31 Q100493791-7A770076-8F62-4D64-957E-BEACA40130F4 @default.
- Q100493791 P356 Q100493791-893D5E2E-5493-417E-97EC-0F3227D62608 @default.
- Q100493791 P50 Q100493791-DC5FC954-8F65-4D29-BB0A-2CEB08F63F13 @default.
- Q100493791 P50 Q100493791-EC55B4EC-BDF3-4047-9FDA-762FD2F3939B @default.
- Q100493791 P577 Q100493791-94F9D5D2-D8A5-49D9-934A-A5C21715E273 @default.
- Q100493791 P698 Q100493791-53A089FB-05BD-42C8-912E-9A519CADBDAD @default.
- Q100493791 P921 Q100493791-1723290c-4735-8441-bbf2-f9d244e28872 @default.
- Q100493791 P356 DTH.14374 @default.
- Q100493791 P698 33029852 @default.
- Q100493791 P1433 Q15766374 @default.
- Q100493791 P1476 "Successful therapy of psoriasis with risankizumab after previous failure of guselkumab and tildrakizumab" @default.
- Q100493791 P2093 "Johannes Mohr" @default.
- Q100493791 P2093 "Michael Peter Schoen" @default.
- Q100493791 P304 "e14374" @default.
- Q100493791 P31 Q13442814 @default.
- Q100493791 P356 "10.1111/DTH.14374" @default.
- Q100493791 P50 Q64537039 @default.
- Q100493791 P50 Q89503764 @default.
- Q100493791 P577 "2020-10-08T00:00:00Z" @default.
- Q100493791 P698 "33029852" @default.
- Q100493791 P921 Q25112466 @default.